Dietary n-3 polyunsaturated fatty acids and endothelium dysfunction induced by lysophosphatidylcholine in Syrian hamster aorta

Metabolism: Clinical and Experimental

Volumn 57, Issue 2, 2008, Pages 233-240

  Lucas, Anthony ^a,b,c   Grynberg, Alain ^a,b,c   Lacour, Bernard ^a,b,c   Goirand, Françoise ^a,b,c  

^a INRA UMR 1154   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c IPSIT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ARACHIDONIC ACID; CELLULOSE; DOCOSAHEXAENOIC ACID; GELATIN; ICOSAPENTAENOIC ACID; INDOMETACIN; LYSOPHOSPHATIDYLCHOLINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; OMEGA 3 FATTY ACID; POTASSIUM CHANNEL; PROSTAGLANDIN SYNTHASE; SODIUM CHLORIDE; STARCH; SUCROSE; SULFAPHENAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIETARY INTAKE; ENDOTHELIAL DYSFUNCTION; FAT INTAKE; GAS CHROMATOGRAPHY; LIPID COMPOSITION; MALE; NONHUMAN; NUTRITIONAL ASSESSMENT; PRIORITY JOURNAL; SYRIAN HAMSTER; THORACIC AORTA; VASODILATATION;

ACETYLCHOLINE; ANIMALS; AORTA, THORACIC; CRICETINAE; DIETARY SUPPLEMENTS; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FATTY ACIDS, OMEGA-3; LYSOPHOSPHATIDYLCHOLINES; MESOCRICETUS; MUSCLE RELAXATION; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE; PHOSPHOLIPASES A2; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; RANDOM ALLOCATION;

EID: 38049057835     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2007.09.006     Document Type: Article

References (38)

1. Schmidt E.B., and Dyerberg J. Omega-3 fatty acids. Current status in cardiovascular medicine. Drugs 47 (1994) 405-424
2. Horrocks L.A., and Yeo Y.K. Health benefits of docosahexaenoic acid (DHA). Pharmacol Res 40 (1999) 211-225
3. Mori T.A., Bao D.Q., Burke V., Puddey I.B., and Beilin L.J. Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans. Hypertension 34 (1999) 253-260
4. Rousseau D., Helies-Toussaint C., Moreau D., Raederstorff D., and Grynberg A. Dietary n-3 PUFAs affect the blood pressure rise and cardiac impairments in a hyperinsulinemia rat model in vivo. Am J Physiol Heart Circ Physiol 285 (2003) H1294-H1302
5. Siscovick D.S., Raghunathan T.E., King I., Weinmann S., Wicklund K.J., Albright G., et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 274 (1995) 1363-7136
6. Billman G.E., Kang J.X., and Leaf A. Prevention of ischemia-induced cardiac sudden death by n-3 polyunsaturated fatty acids in dogs. Lipids 32 (1997) 1161-1168
7. Von Schacky C., Angerer P., Kothny W., Theisen K., and Mudra H. The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 130 (1999) 554-562
8. Thies F., Garry J.M., Yaqoob P., Rerkasem K., Williams J., Shearman C.P., et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet 361 (2003) 477-485
9. Mori T.A., Burke V., Puddey I.B., Watts G.F., O'Neal D.N., Best J.D., et al. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am J Clin Nutr 71 (2000) 1085-1094
10. Das U.N. Long-chain polyunsaturated fatty acids, endothelial lipase and atherosclerosis. Prostaglandins Leukot Essent Fatty Acids 72 (2005) 173-179
11. Mori T.A., Watts G.F., Burke V., Hilme E., Puddey I.B., and Beilin L.J. Differential effects of eicosapentaenoic acid and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic, overweight men. Circulation 102 (2000) 1264-1269
12. Kothny W., Angerer P., Stork S., and von Schacky C. Short term effects of omega-3 fatty acids on the radial artery of patients with coronary artery disease. Atherosclerosis 140 (1998) 181-186
13. Christon R., Marette A., Badeau M., Bourgoin F., Melancon S., and Bachelard H. Fatty acid-induced changes in vascular reactivity in healthy adult rats. Metabolism 54 (2005) 1600-1609
14. Goirand F., Ovide-Bordeaux S., Renaud J.F., Grynberg A., and Lacour B. Effect of dietary docosahexaenoic acid on the endothelium-dependent vasorelaxation in diabetic rats. Clin Exp Pharmacol Physiol 32 (2005) 184-190
15. Napoli C., Paterno R., Faraci F.M., Taguchi H., Postiglione A., and Heistad D.D. Mildly oxidized low-density lipoprotein impairs responses of carotid but not basilar artery in rabbits. Stroke 28 (1997) 2266-2271 [discussion 2271-2]
16. Kugiyama K., Kerns S.A., Morrisett J.D., Roberts R., and Henry P.D. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature 344 (1990) 160-162
17. Chen L., Liang B., Froese D.E., Liu S., Wong J.T., Tran K., et al. Oxidative modification of low density lipoprotein in normal and hyperlipidemic patients: effect of lysophosphatidylcholine composition on vascular relaxation. J Lipid Res 38 (1997) 546-553
18. Eizawa H., Yui Y., Inoue R., Kosuga K., Hattori R., Aoyama T., et al. Lysophosphatidylcholine inhibits endothelium-dependent hyperpolarization and N-omega-nitro-l-arginine/indomethacin-resistant endothelium-dependent relaxation in the porcine coronary artery. Circulation 92 (1995) 3520-3526
19. Froese D.E., McMaster J., Man R.Y., Choy P.C., and Kroeger E.A. Inhibition of endothelium-dependent vascular relaxation by lysophosphatidylcholine: impact of lysophosphatidylcholine on mechanisms involving endothelium-derived nitric oxide and endothelium-derived hyperpolarizing factor. Mol Cell Biochem 197 (1999) 1-6
20. Millanvoye-Van Brussel E., Topal G., Brunet A., Do Pham T., Deckert V., Rendu F., et al. Lysophosphatidylcholine and 7-oxocholesterol modulate Ca2+ signals and inhibit the phosphorylation of endothelial NO synthase and cytosolic phospholipase A2. Biochem J 380 (2004) 533-539
21. Rayner T.E., and Howe P.R. Purified omega-3 fatty acids retard the development of proteinuria in salt-loaded hypertensive rats. J Hypertens 13 (1995) 771-780
22. Grynberg A., Fantini E., Athias P., Degois M., Guenot L., Courtois M., et al. Modification of the n-6/n-3 fatty acid ratio in the phospholipids of rat ventricular myocytes in culture by the use of synthetic media: functional and biochemical consequences in normoxic and hypoxic conditions. J Mol Cell Cardiol 20 (1988) 863-874
23. Folch J., Lees M., and Sloane Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226 (1957) 497-509
24. Morrison W.R., and Smith L.M. Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanol. J Lipid Res 53 (1964) 600-608
25. Kris-Etherton P.M., and Dietschy J. Design criteria for studies examining individual fatty acid effects on cardiovascular disease risk factors: human and animal studies. Am J Clin Nutr 65 (1997) 1590S-1596S
26. Nistor A., Bulla A., Filip D., and Radu A. The hyperlipidemic hamster as a model of experimental atherosclerosis. Atherosclerosis 68 (1987) 159-173
27. Miwa Y., Hirata K., Kawashima S., Akita H., and Yokoyama M. Lysophosphatidylcholine inhibits receptor-mediated Ca2+ mobilization in intact endothelial cells of rabbit aorta. Arterioscler Thromb Vasc Biol 17 (1997) 1561-1567
28. Engler M.M., Engler M.B., Kroetz D.L., Boswell K.D., Neeley E., and Krassner S.M. The effects of a diet rich in docosahexaenoic acid on organ and vascular fatty acid composition in spontaneously hypertensive rats. Prostaglandins Leukot Essent Fatty Acids 61 (1999) 289-295
29. Tagawa T., Hirooka Y., Shimokawa H., Hironaga K., Sakai K., Oyama J., et al. Long-term treatment with eicosapentaenoic acid improves exercise-induced vasodilation in patients with coronary artery disease. Hypertens Res 25 (2002) 823-829
30. Abeywardena M.Y., and Head R.J. Dietary polyunsaturated fatty acid and antioxidant modulation of vascular dysfunction in the spontaneously hypertensive rat. Prostaglandins Leukot Essent Fatty Acids 65 (2001) 91-97
31. Okuda Y., Kawashima K., Sawada T., Tsurumaru K., Asano M., Suzuki S., et al. Eicosapentaenoic acid enhances nitric oxide production by cultured human endothelial cells. Biochem Biophys Res Commun 232 (1997) 487-491
32. Omura M., Kobayashi S., Mizukami Y., Mogami K., Todoroki-Ikeda N., Miyake T., et al. Eicosapentaenoic acid (EPA) induces Ca(2+)-independent activation and translocation of endothelial nitric oxide synthase and endothelium-dependent vasorelaxation. FEBS Lett 487 (2001) 361-366
33. Golfman L.S., Haughey N.J., Wong J.T., Jiang J.Y., Lee D., Geiger J.D., et al. Lysophosphatidylcholine induces arachidonic acid release and calcium overload in cardiac myoblastic H9c2 cells. J Lipid Res 40 (1999) 1818-1826
34. Oestvang J., Anthonsen M.W., and Johansen B. Role of secretory and cytosolic phospholipase A(2) enzymes in lysophosphatidylcholine-stimulated monocyte arachidonic acid release. FEBS Lett 555 (2003) 257-262
35. Zembowicz A., Jones S.L., and Wu K.K. Induction of cyclooxygenase-2 in human umbilical vein endothelial cells by lysophosphatidylcholine. J Clin Invest 96 (1995) 1688-1692
36. Campbell W.B., Gebremedhin D., Pratt P.F., and Harder D.R. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res 78 (1996) 415-423
37. Hoepfl B., Rodenwaldt B., Pohl U., and De Wit C. EDHF, but not NO or prostaglandins, is critical to evoke a conducted dilation upon ACh in hamster arterioles. Am J Physiol Heart Circ Physiol 283 (2002) H996-H1004
38. Kuhlmann C.R., Schafer M., Li F., Sawamura T., Tillmanns H., Waldecker B., et al. Modulation of endothelial Ca(2+)-activated K(+) channels by oxidized LDL and its contribution to endothelial proliferation. Cardiovasc Res 60 (2003) 626-634